Electrotrichogenesis

Electrotrichogenesis (ETG) involves the stimulation of hair follicles on the scalp with the electric charge of an electrostatic field.

Three studies are listed in the PubMed database relating to the technique.

Electrotrichogenesis was approved in Europe with the CE mark, as a medical device. It was also approved by Health Canada and the Australian health office.

Further reading

• Nataloni, Rochelle (July 1, 2005). "Electrotherapeutic device improves appearance of thinning hair". Dermatology Times. Archived from the original on March 1, 2012.
• Sawaya ME, Shapiro J (2000). "Alopecia: unapproved treatments or indications". Clin. Dermatol. 18 (2): 177–86. doi:10.1016/s0738-081x(99)00108-x. PMID 10742626..
• Electrotrichogenesis was also approved by KFDA (Korean Food and Drug Administration) http://www.haircell.co.kr/index.php
• Report Dr. Chu (2003) - Imperial College of Science. Technology and Medicine, Hammersmith Hospital . London (UK) https://web.archive.org/web/20151112014612/http://www.nuhairuk.co.uk/pdf/DrChu'sReport.pdf
• Pilla, Arthur (2006). "Electromagnetic fields as first messenger in biological signaling: Application to calmodulin-dependent signaling in tissue repair". Biochimica et Biophysica Acta (BBA) - General Subjects. 1810 (12): 1236–1245. doi:10.1016/j.bbagen.2011.10.001. PMID 22005645.

External links

• Reuters news info on Current Technology Corporation, a company that offers electrotrichogenesis treatments.